Skip to main content
. 2023 Apr 27;9(6):841ā€“846. doi: 10.1001/jamaoncol.2023.0187

Figure. Association of HER2DX Pathologic Complete Response (pCR) Groups With Response to Pertuzumab in a Combined Patient-Level Analysis (Nā€‰=ā€‰282).

Figure.

Data are from the neoadjuvant cohorts in the GOM-HGUGM-2018-05 (GOM) and I-SPY2 trials. OR indicates odds ratio.